@article {19891,
	title = {Genetic Variations of Circulating Adiponectin Levels Modulate Changes in Appetite in Response to Weight-Loss Diets},
	journal = {J Clin Endocrinol MetabJ Clin Endocrinol MetabJ Clin Endocrinol Metab},
	volume = {102},
	number = {1},
	year = {2017},
	note = {Ma, WenjieHuang, TaoHeianza, YorikoWang, TiangeSun, DianjianyiTong, JennyWilliamson, Donald ABray, George ASacks, Frank MQi, LuR01 DK078616/DK/NIDDK NIH HHS/R01 DK091718/DK/NIDDK NIH HHS/P30 DK046200/DK/NIDDK NIH HHS/R21 HL126024/HL/NHLBI NIH HHS/R01 HL034594/HL/NHLBI NIH HHS/U01 DK078616/DK/NIDDK NIH HHS/R01 DK100383/DK/NIDDK NIH HHS/R01 HL071981/HL/NHLBI NIH HHS/J Clin Endocrinol Metab. 2017 Jan 1;102(1):316-325. doi: 10.1210/jc.2016-2909.},
	month = {Jan 1},
	pages = {316-325},
	type = {Randomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov\&$\#$039;t},
	edition = {2016/11/15},
	abstract = {Context: Adiponectin plays key roles in regulating appetite and food intake. Objective: To investigate interactions between the genetic risk score (GRS) for adiponectin levels and weight-loss diets varying in macronutrient intake on long-term changes in appetite and adiponectin levels. Design, Setting, and Participants: A GRS was calculated based on 5 adiponectin-associated variants in 692 overweight adults from the 2-year Preventing Overweight Using Novel Dietary Strategies trial. Main Outcome Measures: Repeated measurements of plasma adiponectin levels and appetite-related traits, including cravings, fullness, prospective consumption, and hunger. Results: Dietary fat showed nominally significant interactions with the adiponectin GRS on changes in appetite score and prospective consumption from baseline to 6 months (P for interaction = 0.014 and 0.017, respectively) after adjusting for age, sex, ethnicity, baseline body mass index, and baseline respective outcome values. The GRS for lower adiponectin levels was associated with a greater decrease in appetite (P \&lt; 0.001) and prospective consumption (P = 0.008) among participants consuming a high-fat diet, whereas no significant associations were observed in the low-fat group. Additionally, a significant interaction was observed between the GRS and dietary fat on 6-month changes in adiponectin levels (P for interaction = 0.021). The lower GRS was associated with a greater increase in adiponectin in the low-fat group (P = 0.02), but it was not associated with adiponectin changes in the high-fat group (P = 0.31). Conclusions: Our findings suggest that individuals with varying genetic architecture of circulating adiponectin may respond divergently in appetite and adiponectin levels to weight-loss diets varying in fat intake.},
	keywords = {*Diet, Reducing, Adiponectin/*blood/*genetics, Adult, Appetite/drug effects/*physiology, Biomarkers/analysis, Early Medical Intervention, Female, Follow-Up Studies, Genetic Predisposition to Disease, Genotype, Humans, Male, Middle Aged, Overweight/blood/*drug therapy/genetics, Polymorphism, Single Nucleotide/*genetics, Prognosis, Weight Loss/*drug effects/genetics},
	isbn = {1945-7197 (Electronic)0021-972X (Linking)},
	author = {W. Ma and Huang, T. and Heianza, Y. and T. Wang and Sun, D. and Tong, J. and Williamson, D. A. and Bray, G. A. and Sacks, F. M. and Qi, L.}
}
